Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-03 8:04 pm Purchase | 2024-12-26 | 13G | GAXOS.AI INC PAR $0.0001 GXAI | Mitchell P. Kopin | 363,625 4.990% | 70,728![]() (+24.15%) | Filing History |
| 2024-12-30 5:39 pm Purchase | 2024-12-22 | 13G | VIVOS THERAPEUTICS INC VVOS | Mitchell P. Kopin | 297,315 4.990% | 297,315![]() (New Position) | Filing History |
| 2024-12-27 5:05 pm Purchase | 2024-12-19 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 90,987 4.990% | 45,782![]() (+101.28%) | Filing History |
| 2024-12-26 4:23 pm Purchase | 2024-12-18 | 13G | GAXOS.AI INC PAR $0.0001 GXAI | Mitchell P. Kopin | 292,897 4.990% | 292,897![]() (New Position) | Filing History |
| 2024-11-13 11:20 am Sale | 2024-09-30 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 45,205 4.990% | -53,840![]() (-54.36%) | Filing History |
| 2024-11-13 11:19 am Sale | 2024-09-30 | 13G | NUVVE HOLDING CORP. COM PAR $0 NVVE | Mitchell P. Kopin | 857 4.990% | -170![]() (-16.55%) | Filing History |
| 2024-11-13 11:19 am Sale | 2024-09-30 | 13G | PHARMACYTE BIOTECH INC PMCB | Mitchell P. Kopin | 793,747 9.990% | -109,665![]() (-12.14%) | Filing History |
| 2024-11-13 11:18 am Purchase | 2024-09-30 | 13G | INNOVATIVE EYEWEAR INC LUCY | Mitchell P. Kopin | 126,073 4.990% | 74,193![]() (+143.01%) | Filing History |
| 2024-11-13 11:18 am Sale | 2024-09-30 | 13G | PRF TECHNOLOGIES LTD SHS 2 PRFX | Mitchell P. Kopin | 5,240 4.500% | -4,840![]() (-48.02%) | Filing |
| 2024-11-13 11:18 am Unchanged | 2024-09-30 | 13G | NAYA BIOSCIENCES, INC. NAYA | Mitchell P. Kopin | 15,333 4.500% | 0 (Unchanged) | Filing History |
| 2024-11-13 11:18 am Purchase | 2024-09-30 | 13G | ENVERIC BIOSCIENCES INC NE ENVB | Mitchell P. Kopin | 24,167 3.100% | 12,084![]() (+100.01%) | Filing History |
| 2024-11-13 11:17 am Sale | 2024-09-30 | 13G | TANTECH HLDGS LTD SHS US$0 TANH | Mitchell P. Kopin | 10,956 4.990% | -9,423![]() (-46.24%) | Filing History |
| 2024-11-13 11:16 am Unchanged | 2024-09-30 | 13G | TIAN RUIXIANG HLDGS LTD O TIRX | Mitchell P. Kopin | 10,733 2.200% | 0 (Unchanged) | Filing History |
| 2024-11-13 11:15 am Sale | 2024-09-30 | 13G | INTERACTIVE STRENGTH INC N TRNR | Mitchell P. Kopin | 8,082 4.500% | -5,437![]() (-40.22%) | Filing History |
| 2024-11-13 11:15 am Purchase | 2024-09-30 | 13G | BIO-PATH HLDGS INC PAR $0. BPTH | Mitchell P. Kopin | 194,862 4.990% | 141,162![]() (+262.87%) | Filing History |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | CATHETER PRECISION INC PAR VTAK | Mitchell P. Kopin | 9,544 4.990% | 1,017![]() (+11.93%) | Filing History |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | BONE BIOLOGICS CORP COM DE BBLG | Mitchell P. Kopin | 18,354 4.990% | 1,753![]() (+10.56%) | Filing History |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | PETROS PHARMACEUTICALS INC PTPI | Mitchell P. Kopin | 20,182 4.990% | 13,991![]() (+225.99%) | Filing History |
| 2024-11-13 11:13 am Sale | 2024-09-30 | 13G | AVINGER INC 2023 AVGR | Mitchell P. Kopin | 152,118 4.990% | -56,741![]() (-27.17%) | Filing History |
| 2024-10-03 4:12 pm Purchase | 2024-09-26 | 13G | THERIVA BIOLOGICS, INC. TOVX | Mitchell P. Kopin | 118,526 4.990% | 118,526![]() (New Position) | Filing History |

